首页> 外文期刊>American Journal of Medicine Studies >Genotype and Allele Frequencies of MDR-1 Gene Polymorphism in Jordanian and Sudanese Populations
【24h】

Genotype and Allele Frequencies of MDR-1 Gene Polymorphism in Jordanian and Sudanese Populations

机译:约旦和苏丹人群MDR-1基因多态性的基因型和等位基因频率

获取原文
           

摘要

The aim of this study was to determine the genotype and allele frequencies of MDR1 gene C3435T polymorphism in Jordanian and Sudanese populations, and to compare them with the frequencies established in various ethnic groups. Genotyping was carried out on 116 unrelated Jordanian and 131 Sudanese subjects. The genotypes of polymorphic position C3435T were determined by PCR-RFLP assay. Results showed that 20.7% of the studied Jordanian subjects were homozygous for the CC genotype, 51.7% were heterozygous for the CT genotype and 27.6% were homozygous for the TT genotype. Among Sudanese subjects, the genotype frequencies were: CC 52.7%, CT 42.0% and TT 5.3%. The frequencies of the 3435T variant in the MDR-1 Gene in Jordanians and Sudanese were found to be 0.534 and 0.263, respectively. According to the distribution of the C3435T SNP, Jordanians were resemble Asians and Europeans but were different significantly from Sudanese, while Sudanese were similar to Africans. In conclusion, the observed distribution of the C3435T SNP in the Jordanian and Sudanese populations was within the range detected in other populations. The data obtained may give the basis for predicting effects of drugs that are substrates for MDR-1 in Jordanian and Sudanese populations and may be useful for individualized therapy of some diseases.
机译:这项研究的目的是确定约旦和苏丹人口中MDR1基因C3435T多态性的基因型和等位基因频率,并将其与各个种族中建立的频率进行比较。对116名无关的约旦人和131名苏丹人进行了基因分型。通过PCR-RFLP分析确定多态性位置C3435T的基因型。结果表明,约旦研究对象中CC基因型为纯合子的占20.7%,CT基因型为纯合子的占51.7%,TT基因型为纯合子的占27.6%。在苏丹受试者中,基因型频率为:CC 52.7%,CT 42.0%和TT 5.3%。发现约旦人和苏丹人的MDR-1基因中3435T变体的频率分别为0.534和0.263。根据C3435T SNP的分布,约旦人与亚洲人和欧洲人相似,但与苏丹人有显着差异,而苏丹人与非洲人相似。总之,在约旦和苏丹人群中观察到的C3435T SNP分布在其他人群中检测到的范围内。获得的数据可能为预测作为约旦和苏丹人群中MDR-1底物的药物的效果提供基础,并且可能对某些疾病的个体化治疗有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号